PARD (Poniard Pharmaceuticals) Cyclically Adjusted FCF per Share: $0.00 (As of Sep. 2011)


What is Poniard Pharmaceuticals Cyclically Adjusted FCF per Share?

Poniard Pharmaceuticals PARD Cyclically Adjusted FCF per Share is $0.00 as of Sep. 2011.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Poniard Pharmaceuticals's adjusted free cash flow per share for the three months ended in Sep. 2011 was $-1.140. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Sep. 2011.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-02), Poniard Pharmaceuticals's current stock price is $0.0001. Poniard Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2011 was $0.00. Poniard Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is .


Poniard Pharmaceuticals  (OTCPK:PARD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Poniard Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms


Poniard Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PARD vs OBMP, NSPX, ATRX: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poniard Pharmaceuticals Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.



Poniard Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Poniard Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2011 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2011 (Change)*Current CPI (Sep. 2011)
=-1.14/226.8890*226.8890
=-1.140

Current CPI (Sep. 2011) = 226.8890.

Poniard Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200112 -61.387 176.700 -78.823
200203 -63.216 178.800 -80.218
200206 -69.099 179.900 -87.147
200209 -50.955 181.000 -63.874
200212 37.964 180.900 47.615
200303 -37.250 184.200 -45.883
200306 54.653 183.700 67.502
200309 -29.569 185.200 -36.225
200312 -25.112 184.300 -30.915
200403 -39.289 187.400 -47.568
200406 -27.866 189.700 -33.329
200409 -40.394 189.900 -48.262
200412 -41.729 190.300 -49.752
200503 -40.331 193.300 -47.339
200506 -30.497 194.500 -35.575
200509 -24.217 198.800 -27.639
200512 -23.517 196.800 -27.113
200603 -22.853 199.800 -25.951
200606 -12.636 202.900 -14.130
200609 -6.902 202.900 -7.718
200612 -17.126 201.800 -19.255
200703 -12.256 205.352 -13.541
200706 -8.368 208.352 -9.112
200709 -6.448 208.490 -7.017
200712 -13.158 210.036 -14.214
200803 -8.288 213.528 -8.807
200806 -9.465 218.815 -9.814
200809 -10.577 218.783 -10.969
200812 -10.745 210.228 -11.597
200903 -12.762 212.709 -13.613
200906 -8.924 215.693 -9.387
200909 -9.455 215.969 -9.933
200912 -9.193 215.949 -9.659
201003 -7.719 217.631 -8.047
201006 -5.905 217.965 -6.147
201009 -3.210 218.439 -3.334
201012 -4.174 219.179 -4.321
201103 -1.500 223.467 -1.523
201106 -1.131 225.722 -1.137
201109 -1.140 226.889 -1.140

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
Poniard Pharmaceuticals (PARD) has a Cyclically Adjusted FCF per Share of $0.00 as of Sep. 2011. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Cyclically Adjusted FCF per Share too high?
Poniard Pharmaceuticals' current Cyclically Adjusted FCF per Share is $0.00.
How does Poniard Pharmaceuticals' Cyclically Adjusted FCF per Share compare to OBMP and NSPX?
Poniard Pharmaceuticals' Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Cyclically Adjusted FCF per Share of $0.00. The current Cyclically Adjusted FCF per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Cyclically Adjusted FCF per Share is $0.00 as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.